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Chlamydiae are both intriguing obligate intracellular Gram-
negative bacteria and highly successful animal and human
pathogens. Their unique biphasic developmental cycle is charac-
terized by the infectious but metabolically less-active elementary
body (EB), which initiates infection in a susceptible host cell, and
the dividing, intracellular reticulate body (RB). The chlamydiae
hijack host cells for their own purposes and, after infection and
multiplication, emerge from the host cell and spread their hun-
dreds of progeny EB to infect the next cell. Moreover, chlamydiae
are able to survive in an alternative form named the aberrant body
(AB) under stressful in vitro conditions. The AB state has been
defined as the hallmark of persistence—which is herein defined
as the viable but non-infectious state of the chlamydial develop-
mental cycle. The key questions of whether this AB form occurs
in vivo and if this alternative chlamydial form contributes to clin-
ically significant chronic diseases processes such as inflammation,
scarring, and fibrosis are a matter of debate in the chlamydial
research community. These controversies led us to assemble a col-
lection of Opinion, Hypothesis and Theory, Perspective, Review,
and Primary Research Articles to shed light on recent research
findings. This Research Topic showcases the “chlamydial per-
sistent state” from meaning to mechanism on the cellular and
human/animal host level.
The critical dissection of the word “persistence” by Bavoil
(2014) points out that much more is hidden behind this term
than the definition “to stand still permanently” in a suscepti-
ble host. For clinicians, this might represent a bacterial infection
that: (i) has a subclinical course, (ii) can escape host immune
responses; and (iii) is refractory to antibiotic treatment. The lack
of specific diagnostic tests for such “invisible” infections might
even complicate the definition and detection of these infections.
Ongoing asymptomatic infections may even resemble coloniza-
tion, as suggested by very recent data on chlamydial infections in
the gastrointestinal tract. Notably, asymptomatic gastrointestinal
chlamydial infections with recurrent chlamydial fecal shedding
have been observed in the Veterinary Medical field for decades.
For example, subclinical infections with Chlamydia (C.) psittaci
in birds are frequent and these “latently” infected birds pose a sig-
nificant zoonotic risk. Regardless, it is important for investigators
in the Chlamydia field to come to agreement regarding the
“definition” of what constitutes a persistent chlamydial infection.
The persistence phenotype in vitro may be linked to chronic
disease processes in vivo, such as atherosclerosis. C. pneumoniae
has been detected in atherosclerotic lesions of human patients by
multiple methods and C. pneumoniae-induced disease progres-
sion has been demonstrated in rodent models—an association
that propelled several antibiotic treatment trials. The opinion
article by Campbell and Rosenfeld (2014) summarizes the out-
come of these clinical trials and critically reviews their limitations.
Unfortunately, the mixed results of these trials and the conclu-
sion that anti-chlamydial antibiotics should not be recommended
for treatment of patients with coronary heart disease and periph-
eral artery disease may have led to the erroneous assumption
that C. pneumoniae did not play a role in the pathogenesis of
atherosclerosis. The advanced nature of atherosclerotic lesions
questions not only the effectiveness of antibiotic treatment to
eradicate C. pneumoniae but also implicates how challenging the
diagnosis of the agent may be. Puolakkainen (2013) discusses the
difficulty in differentiating between acute and chronic infections
due to the lack of reliable “persistence” biomarkers and commer-
cially available tests. Whole proteome assays have been developed
for research purposes but need careful validation on selected spec-
imens from well-studied patient populations. The most desirable
test to detect persistent infections would be serum-based, an opti-
mistic goal that remains frustratingly out of reach without a better
understanding of what persistence actually is and the molecular
mechanisms that underly induction, maintenance, and recovery
from this non-replicative state (Bavoil, 2014).
Azithromycin and tetracycline/doxycycline are considered the
first-line antibiotics to treat genital chlamydial infection. In vitro,
it has been shown that penicillin G exposure induces C. trachoma-
tis persistent/aberrant forms. In culture, persistent organisms
also resist killing by azithromycin. Because penicillins are com-
monly utilized to treat other bacterial infections, this may impact
patients with concurrent asymptomatic chlamydial infections.
Kintner et al. (2014) investigated if commonly prescribed beta-
lactam antibiotics are able to induce C. trachomatis serovar E
persistence/stress in culture. All penicillins tested induced viable
but non-infectious chlamydial forms at clinically relevant con-
centrations, which might represent one mechanism by which
chlamydiae resist antimicrobial therapy in vivo. In a related
study, Ong et al. (2013) determined whether the C. trachomatis
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serine protease HtrA (CtHtrA) was required for recovery from
penicillin-induced persistence/stress response. CtHtrA is essential
for the replicative phase and the addition of a chemical inhibitor
(JO146) of CtHtrA was lethal when added to the cultures at
mid-replicative cycle. The same inhibitor prevented reversion and
recovery from penicillin persistence, demonstrating the essential
role of CtHtrA during recovery from stressful conditions. Not
only is HtrA the first chlamydial gene shown to play a role in
recovery from persistence, HtrA inhibitors might prove to be use-
ful for eradicating both productively replicating and persistent
chlamydiae.
Persistent infections have been described in a magnitude of
experimental cell culture models—all of which involve apply-
ing some type of stressor to the chlamydial culture. The most
well-described culture model of persistence is the IFN-γ-induced
system. In human cells, IFN-γ exposure upregulates indoleamine
2,3-dioxygenase (IDO), decreases intracellular tryptophan (Trp),
and induces chlamydial persistence. Chlamydial infectivity can be
rescued by addition of exogenous Trp. Four manuscripts in this
special issue explore novel aspects of IFN-stimulated persistence.
Jerchel et al. (2014) explored C. trachomatis persistence and reac-
tivation and host cytokine responses under normoxic and hypoxic
conditions. Oxygen concentrations in the female urogenital tract
are physiologically low and further diminished by inflammatory
processes. This study demonstrated that hypoxia leads to reac-
tivation of INF-γ-induced persistent C. trachomatis infections.
Moreover, host immune signaling responses were diminished,
as reflected by reduced activation of MAP-kinase p44/42 and
reduced expression of pro-inflammatory cytokines IL-6 and IL-
8. Recent sophisticated comparative evaluation of Chlamydiales
proteomes for Trp content is reviewed by Bonner et al. (2014).
Selection for higher-than-predicted (Up-Trp) Trp content, com-
pared to lower-than-predicted (Down-Trp) content, is key for the
persistent state and phylogenetically different for Chlamydiaceae
compared to other chlamydiae families. Previous studies indicate
that there is a significant difference in the capacity of ocular and
genital C. trachomatis serovars to deal with tryptophan depriva-
tion. Genital serovars encode a functional tryptophan synthase
and can use indole to bypass INF-γ-induced tryptophan starva-
tion. The perturbed vaginal microbiome as a source of indole
in vivo is highlighted in the Hypothesis and Theory article by
Aiyar et al. (2014). Indole has been found in vaginal secretions
from patients with bacterial vaginosis and indole-producing bac-
teria have been isolated. Thus, when studying genital chlamydial
infections in the future, it will be necessary to consider both
the elicited host immune response and the local environmen-
tal conditions created by the host microbiome. Transferring such
knowledge into the patient’s situation is reflected in the article by
Lewis et al. (2014). These authors were able to show persistent
chlamydial growth forms in the human cervix by novel diagnos-
tic approaches. Local IFN-γ levels corresponded to chlamydial
growth pattern and morphology. This study may pave way to
the establishment of potential biomarker panel for assessing the
disease outcome in C. trachomatis infected women.
One ultrastructural feature of persistent chlamydiae observed
inmany cell culture models is production of abundant membrane
vesicles (MVs), which are observed both within the inclusion
and in the host cell cytoplasm. The potential role of these vesi-
cles in host-pathogen interactions is explored by Frohlich et al.
(2014). The generation of MVs is suggested to be an important
mechanism for C. trachomatis intracellular survival of stress. MVs
are not only present in primary human endocervical epithelial
cells infected with C. trachomatis, but also in clinical specimens
from infected patients (Lewis et al., 2014). The potential func-
tion and role of chlamydial MVs in cargo delivery, innate immune
response modulation, exchange of genetic material, and intracel-
lular survival under stress conditions calls for more research in
this field.
The “chlamydial anomaly” refers to the observation that
chlamydial species are sensitive to antibiotics that target the bac-
terial cell wall, such as penicillin, despite the fact that a functional
cell wall has not been detected. This problem is featured in the
research article by De Benedetti et al. (2014). The chlamydial
genome contains a nearly complete cell wall precursor biosynthe-
sis pathway. Chlamydiaceae genomes encode GlyA which in turn
can serve as a source of D-alanine, as exemplified in C. pneu-
moniae. In view of this finding, future research might help
to clarify the structure of cell wall precursor lipid II and the
role of chlamydial penicillin-binding proteins in production of
penicillin-induced aberrant chlamydial forms.
Finally, host-pathogen interplay between multiple pathogenic
microorganisms, such as the porcine epidemic diarrhea virus
(PEDV) co-infection model described in the last paper of this
collection (Schoborg and Borel, 2014), might more appropriately
reflect the in vivo situation than do artificially-induced cell culture
models. In particular, this bacterial-viral co-infection has been
shown to occur in vivo, can be mimicked in experimental porcine
animal models and includes the local environmental conditions
of the gut microbiome.
In summary, this collection highlights the recent findings
in the field of the “persistent” chlamydial state, which might
reflect persistence, re-occurrence, re-infection or colonization in
an animal or human host. The collection also illuminates themul-
tifaceted nature of chlamydial persistence and the complexity that
results from the existence of different models and multiple fac-
tors involved. Moreover, many models have been developed from
in vitro data and applicability to the in vivo situation is, as yet,
undefined. As outlined by Bavoil (2014), our limited understand-
ing of what persistence is needs further research in the future and
will produce greater insight into the host-pathogen interaction.
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